Alunbrig is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Ariad Pharmaceuticals Inc.. The primary component is Brigatinib.
Product ID | 76189-113_76928450-348f-4d49-b086-17866cfb34c6 |
NDC | 76189-113 |
Product Type | Human Prescription Drug |
Proprietary Name | Alunbrig |
Generic Name | Brigatinib |
Dosage Form | Tablet, Coated |
Route of Administration | ORAL |
Marketing Start Date | 2017-04-28 |
Marketing End Date | 2020-12-12 |
Marketing Category | NDA / NDA |
Application Number | NDA208772 |
Labeler Name | ARIAD Pharmaceuticals Inc. |
Substance Name | BRIGATINIB |
Active Ingredient Strength | 30 mg/1 |
Pharm Classes | Kinase Inhibitor [EPC],Tyrosine Kinase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA] |
NDC Exclude Flag | N |
Marketing Start Date | 2017-04-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208772 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-04-28 |
Marketing End Date | 2020-12-12 |
Marketing Category | NDA |
Application Number | NDA208772 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-04-28 |
Marketing End Date | 2020-12-12 |
Ingredient | Strength |
---|---|
BRIGATINIB | 30 mg/1 |
SPL SET ID: | 07b71b73-1ca3-4e78-a787-e458917f1f23 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
63020-090 | Alunbrig | brigatinib |
63020-113 | Alunbrig | brigatinib |
63020-180 | Alunbrig | brigatinib |
63020-198 | Alunbrig | brigatinib |
76189-113 | Alunbrig | Brigatinib |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ALUNBRIG 86797024 5251769 Live/Registered |
ARIAD Pharmaceuticals, Inc. 2015-10-23 |